Drug Trial Radar · NCT05218655
A Safety Study for Previously Treated Vatiquinone (PTC743) Participants With Inherited Mitochondrial Disease
Last checked: Nov 20, 2026Latest source record: Dec 22, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
101
Actual
Start
Jun 22, 2022
Primary completion
Apr 15, 2025
Study completion Apr 15, 2025
Sponsor
- Lead sponsor
- PTC TherapeuticsIndustry
- Sponsor type
- Industry
- First posted
- Feb 1, 2022
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary objective of this study is to assess the safety of vatiquinone in participants with inherited mitochondrial disease who had prior exposure to vatiquinone in a PTC/BioElectron sponsored (previously Edison) clinical study or treatment plan. The study will continue until vatiquinone becomes commercially available or the program is terminated.
Conditions
- Inherited Mitochondrial Disease
Interventions
VatiquinoneDrug
Vatiquinone will be administered per dose and schedule specified in the arm description.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants With Treatment-emergent Adverse Events (TEAEs)Time frame: Baseline (Day 1) up to 30 days after last dose of study drug (956 days)
Locations
26 sites in 7 countries. Site status is shown where the registry gives one.
University of California, San Diego Altman Clinical and Translational Research Institute
La Jolla, California
Stanford University
Stanford, California
Yale Medicine
New Haven, Connecticut
Children's National
Washington D.C., District of Columbia
Child Neurology Center of Northwest Florida
Gulf Breeze, Florida
The Johns Hopkins University
Baltimore, Maryland
Columbia University Medical Center - CUMC
New York, New York
Akron Children's Hospital
Akron, Ohio
Cleveland Clinic
Cleveland, Ohio
Children's Hospital of Philadelphia - CHOP
Philadelphia, Pennsylvania
Medical University of South Carolina - MUSC
Charleston, South Carolina
Baylor College of Medicine
Houston, Texas
UT Health The University of Texas
Houston, Texas
Seattle Children Hospital
Seattle, Washington
Chu Angers
Angers, France
CHU Montpellier - Hopital Saint-Eloi
Montpellier, France
Hopital Necker-Enfants Malades
Paris, France
Hôpital de Hautepierre - Hôpitaux Universitaires de Strasbourg
Strasbourg, France
Ospedale Pediatrico Bambino Gesù
Roma, Italy
PTC Clinical Site
Japanese City, Japan
Instytut Pomnik - Centrum Zdrowia Dziecka
Warsaw, Poland
Hospital Sant Joan de Déu
Barcelona, Spain
Hospital Universitario 12 de Octubre
Madrid, Spain
Hospital Ruber Internacional
Madrid, Spain
Great Ormond Street Hospital for Children NHS Foundation Trust
London, United Kingdom
The Newcastle Upon Tyne Hospitals NHS Foundation Trust
Newcastle upon Tyne, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.